Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.49 - $0.61 $227,317 - $282,987
463,914 Added 358.56%
593,296 $361,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $0.93 $0 - $120,325
129,382 New
129,382 $54,000
Q2 2021

Aug 11, 2021

SELL
$2.18 - $4.66 $331,146 - $707,863
-151,902 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$1.3 - $3.24 $197,472 - $492,162
151,902 New
151,902 $396,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.